Cowen exclusively advised EMZ Partners (“EMZ”) on the acquisition of a majority stake in FotoFinder Systems GmbH (“FotoFinder”), the leading provider of skin visualization technology for early skin cancer detection and aesthetics. Co-Founder and main shareholder Rudolf Mayer withdraws from his shareholding position and entrusts the future success of FotoFinder to co-founder Andreas Mayer, further Mayer family members as well as selected management team members. All of the latter reinvest a significant portion of their proceeds or become new shareholders. Completion of this transaction is expected to take place in Q2 2022. Cowen acted as both M&A and Debt Advisor for EMZ.
Founded in 1991, FotoFinder offers products and services to dermatologists, dermatology clinics, hospitals, screening centers and research institutes. The solutions sold combine proprietary AI-based software with industry-leading Automated Total Body Mapping capabilities as well as video dermoscopy devices, forming integrated system solutions for skin imaging. The company fosters close collaborations with universities and opinion leaders in dermatology, and, through its FotoFinder Online Academy, enjoys access to a global network of dermatologists, supplemented by a service portfolio including maintenance, trainings and second opinion services.
“We have been very impressed by the journey of FotoFinder over the recent years to its current market-leading position, and how this successful development has been driven by the Mayer family and the management team. We are very much looking forward to pooling our expertise and successfully reaching the next level of the company together. Thank you to Cowen for their enthusiastic and engaged support “, says Klaus Maurer, Managing Partner, EMZ.
Andreas Mayer, CEO of FotoFinder, adds:” We are very proud of what we as FotoFinder family have achieved to date, but we are also aware of the future opportunities and challenges. Together with EMZ Partners as new partner, we can further expand our offering and capabilities to access markets beyond our current reach. We are delighted to having found a partner who shares our vision and supports our strategic initiatives.”
EMZ is a leading European investment firm that acts as a partner for medium-sized companies and their respective management teams. Its activities focus on investments in the DACH region as well as France with a clear intention to operate and support founders, family shareholders, and managers. The core of EMZ’s philosophy is a significant reinvest of the management team to create a mutual partnership as shareholders.
EMZ is majority-owned by its own employees and has a base of European institutional investors. The current fund has a volume of more than €1.0 billion and its investment size ranges from €10 to €150 million.
The family-run business with headquarters in Bad Birnbach (Bavaria), Germany, has been developing medical imaging systems since 1991. It is specialized in skin imaging for early skin cancer detection by means of Automated Total Body Mapping (ATBM), Artificial Intelligence (AI) and digital dermoscopy, as well as in trichoscopy, psoriasis documentation and imaging in aesthetics. In addition, FotoFinder systems are used in clinical dermatology and clinical research. Subsidiaries in Italy, UK and the U.S., as well as a global partner network support the company’s worldwide presence, serving clients in more than 90 countries.
+49 89 2000 393 0
+49 172 6212 755
+49 89 2000 393 0